View in EDS

Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance.

Saved in:
Bibliographic Details
Title: Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance.
Authors: Jane EP; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Premkumar DR; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania. daniel.premkumar@chp.edu ian.pollack@chp.edu.; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; University of Pittsburgh Cancer Institute Brain Tumor Center, Pittsburgh, Pennsylvania., Thambireddy S; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania., Golbourn B; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania., Agnihotri S; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; University of Pittsburgh Cancer Institute Brain Tumor Center, Pittsburgh, Pennsylvania., Bertrand KC; Texas Children's Hospital, Baylor College of Medicine, Houston, Texas., Mack SC; Texas Children's Hospital, Baylor College of Medicine, Houston, Texas., Myers MI; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania., Chattopadhyay A; Molecular Biology Information Service, University of Pittsburgh, Pittsburgh, Pennsylvania., Taylor DL; Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Schurdak ME; Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Stern AM; Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Pollack IF; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania. daniel.premkumar@chp.edu ian.pollack@chp.edu.; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; University of Pittsburgh Cancer Institute Brain Tumor Center, Pittsburgh, Pennsylvania.
Source: Molecular cancer research : MCR [Mol Cancer Res] 2020 Jul; Vol. 18 (7), pp. 1004-1017. Date of Electronic Publication: 2020 Apr 01.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101150042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3125 (Electronic) Linking ISSN: 15417786 NLM ISO Abbreviation: Mol Cancer Res Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 32238439
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting NAD<superscript>+</superscript> Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jane+EP%22">Jane EP</searchLink>; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Premkumar+DR%22">Premkumar DR</searchLink>; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania. daniel.premkumar@chp.edu ian.pollack@chp.edu.; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; University of Pittsburgh Cancer Institute Brain Tumor Center, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Thambireddy+S%22">Thambireddy S</searchLink>; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Golbourn+B%22">Golbourn B</searchLink>; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Agnihotri+S%22">Agnihotri S</searchLink>; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania.; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; University of Pittsburgh Cancer Institute Brain Tumor Center, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Bertrand+KC%22">Bertrand KC</searchLink>; Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Mack+SC%22">Mack SC</searchLink>; Texas Children's Hospital, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Myers+MI%22">Myers MI</searchLink>; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Chattopadhyay+A%22">Chattopadhyay A</searchLink>; Molecular Biology Information Service, University of Pittsburgh, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Taylor+DL%22">Taylor DL</searchLink>; Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Schurdak+ME%22">Schurdak ME</searchLink>; Cancer Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Stern+AM%22">Stern AM</searchLink>; Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania.; Department of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Pollack+IF%22">Pollack IF</searchLink>; Department of Neurosurgery, University of Pittsburgh, Pittsburgh, Pennsylvania. daniel.premkumar@chp.edu ian.pollack@chp.edu.; University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.; University of Pittsburgh Cancer Institute Brain Tumor Center, Pittsburgh, Pennsylvania.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101150042%22">Molecular cancer research : MCR</searchLink> [Mol Cancer Res] 2020 Jul; Vol. 18 (7), pp. 1004-1017. <i>Date of Electronic Publication: </i>2020 Apr 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101150042 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3125 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215417786%22">15417786 </searchLink><i>NLM ISO Abbreviation: </i>Mol Cancer Res <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32238439
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/1541-7786.MCR-19-0669
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1004
    Titles:
      – TitleFull: Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jane EP
      – PersonEntity:
          Name:
            NameFull: Premkumar DR
      – PersonEntity:
          Name:
            NameFull: Thambireddy S
      – PersonEntity:
          Name:
            NameFull: Golbourn B
      – PersonEntity:
          Name:
            NameFull: Agnihotri S
      – PersonEntity:
          Name:
            NameFull: Bertrand KC
      – PersonEntity:
          Name:
            NameFull: Mack SC
      – PersonEntity:
          Name:
            NameFull: Myers MI
      – PersonEntity:
          Name:
            NameFull: Chattopadhyay A
      – PersonEntity:
          Name:
            NameFull: Taylor DL
      – PersonEntity:
          Name:
            NameFull: Schurdak ME
      – PersonEntity:
          Name:
            NameFull: Stern AM
      – PersonEntity:
          Name:
            NameFull: Pollack IF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2020 Jul
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 1557-3125
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Molecular cancer research : MCR
              Type: main
ResultId 1